Literature DB >> 26433503

A historic and scientific review of breast cancer: The next global healthcare challenge.

Sven Becker1.   

Abstract

Breast cancer is fast becoming the leading cause of oncologic morbidity and mortality among women worldwide. Demographic changes in Asia, Southeast Asia, and South America will further accelerate this trend. Different specialties are involved in the treatment of breast cancer patients: gynecology, surgery, pathology, hematology/oncology, radiology, radiation oncology, and nuclear medicine. Optimal results are seen in countries providing standardized breast cancer care in certified breast centers. The present article provides an overview of current state-of-the-art treatment strategies and explains the contributions of different specialties to optimal and individualized care for breast cancer patients. Breast cancer will be one of the most important health issues facing physicians involved with women's health and a basic understanding of current treatment objectives will be essential medical knowledge for everyone taking care of female patients.
Copyright © 2015. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Breast cancer diagnosis; Breast cancer systemic therapy; Breast cancer treatment

Mesh:

Year:  2015        PMID: 26433503     DOI: 10.1016/j.ijgo.2015.03.015

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  29 in total

1.  Budget impact analysis of a breast rapid diagnostic unit.

Authors:  M Elmi; H Hussein; S Nofech-Mozes; B Curpen; A Leahey; N Look Hong
Journal:  Curr Oncol       Date:  2017-06-27       Impact factor: 3.677

Review 2.  Molecular insights into the interplay between adiposity, breast cancer and bone metastasis.

Authors:  Sneha Soni; Meaghan Torvund; Chandi C Mandal
Journal:  Clin Exp Metastasis       Date:  2021-02-16       Impact factor: 5.150

Review 3.  Cellular and molecular mechanisms underlying alcohol-induced aggressiveness of breast cancer.

Authors:  Yongchao Wang; Mei Xu; Zun-Ji Ke; Jia Luo
Journal:  Pharmacol Res       Date:  2016-12-08       Impact factor: 7.658

4.  MicroRNA 362-3p Reduces hERG-related Current and Inhibits Breast Cancer Cells Proliferation.

Authors:  Abdullah A Assiri; Noha Mourad; Minghai Shao; Patrick Kiel; Wanqing Liu; Todd C Skaar; Brian R Overholser
Journal:  Cancer Genomics Proteomics       Date:  2019 Nov-Dec       Impact factor: 4.069

Review 5.  Triple-negative breast cancer: A run-through of features, classification and current therapies.

Authors:  Meghana Manjunath; Bibha Choudhary
Journal:  Oncol Lett       Date:  2021-05-05       Impact factor: 2.967

6.  Evaluation of the accuracy of mammography, ultrasound and magnetic resonance imaging in suspect breast lesions.

Authors:  Renato de Oliveira Pereira; Larissa Almondes da Luz; Diego Cipriano Chagas; Jefferson Rodrigues Amorim; Elmo de Jesus Nery-Júnior; Araci Castelo Branco Rodrigues Alves; Flávio Teixeira de Abreu-Neto; Maria da Conceição Barros Oliveira; Danylo Rafhael Costa Silva; José Maria Soares-Júnior; Benedito Borges da Silva
Journal:  Clinics (Sao Paulo)       Date:  2020-07-22       Impact factor: 2.365

7.  Authors' Reply "Comments: Evaluation of the accuracy of mammography, ultrasound, and magnetic resonance imaging in suspect breast lesions".

Authors:  Renato de Oliveira Pereira; Larissa Almondes da Luz; Diego Cipriano Chagas; Jefferson Rodrigues Amorim; Elmo de Jesus Nery-Junior; Araci Castelo Branco Rodrigues Alves; Flávio Teixeira de Abreu-Neto; Maria da Conceicão Barros Oliveira; Danylo Rafhael Costa Silva; José Maria Soares-Júnior; Benedito Borges da Silva
Journal:  Clinics (Sao Paulo)       Date:  2021-06-14       Impact factor: 2.365

8.  A Signature of Four Circulating microRNAs as Potential Biomarkers for Diagnosing Early-Stage Breast Cancer.

Authors:  Maha M Itani; Farah J Nassar; Arafat H Tfayli; Rabih S Talhouk; Ghada K Chamandi; Abdul Rahman S Itani; Joelle Makoukji; Rose-Mary N Boustany; Lifang Hou; Nathalie K Zgheib; Rihab R Nasr
Journal:  Int J Mol Sci       Date:  2021-06-06       Impact factor: 5.923

9.  miR-126 reduces trastuzumab resistance by targeting PIK3R2 and regulating AKT/mTOR pathway in breast cancer cells.

Authors:  Rao Fu; Jing-Shan Tong
Journal:  J Cell Mol Med       Date:  2020-05-15       Impact factor: 5.310

10.  ER+ Breast Cancer Strongly Depends on MCL-1 and BCL-xL Anti-Apoptotic Proteins.

Authors:  Clara Alcon; Jorge Gómez Tejeda Zañudo; Reka Albert; Nikhil Wagle; Maurizio Scaltriti; Anthony Letai; Josep Samitier; Joan Montero
Journal:  Cells       Date:  2021-07-02       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.